Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices

PACE - Pacing and Clinical Electrophysiology

Volumn 38, Issue 8, 2015, Pages 925-933

  Lee, William ^a   Tay, Andre ^a   Subbiah, Rajesh N ^a   Walker, Bruce D ^a   Kuchar, Dennis L ^a   Muthiah, Kavitha ^a   Macdonald, Peter S ^a   Keogh, Anne M ^a   Kotlyar, Eugene ^a   Jabbour, Andrew ^a   Spratt, Philip ^a   Jansz, Paul C ^a   Granger, Emily ^a   Dhital, Kumud ^a   Hayward, Christopher S ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

congestive heart failure; defibrillation ICD; heart transplantation; VT

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDY; SUDDEN CARDIAC DEATH; SURVIVAL RATE; TREATMENT OUTCOME; HEART ASSIST DEVICE; MIDDLE AGED; MORTALITY;

ADULT; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84938211767     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12654     Document Type: Article

References (25)

1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, et al., ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Vardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 128: e240-327.
2. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, et al., The Registry of the International Society for Heart and Lung Transplantation: 29th Official Adult Heart Transplant Report-2012. J Heart Lung Transplant 2012; 31: 1052-1064.
3. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani RD, Miller MA, Baldwin T, et al., Fifth INTERMACS annual report: Risk factor analysis from more than 6000 mechanical circulatory support patients. J Heart Lung Transplant 2013; 32: 141-156.
4. Moss AJ, Zareba W, Jackson H, Wilber DJ, Cannom DS, Daubert JP, Higins SL, et al., Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al., Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
6. Betts TR, Sadarmin PP, Tomlinson DR, Rajappan K, Wong KCK, Bono JP, Bashir Y,. Absolute risk reduction in total mortality with implantable cardioverter defibrillators: Analysis of primary and secondary prevention trial data to aid risk benefit analysis. Europace 2013; 15: 813-819.
7. Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, Morgan JA, et al., The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: Executive Summary. J Heart Lung Transplant 2013; 32: 157-187.
8. Refaat MM, Toshikazu T, Kormos RL, McNamara D, Teuteberg J, Winowich S, London B, et al., Survival benefit of implantable cardioverter defibrillators in left ventricular assist device-supported heart failure patients. J Card Fail 2012; 18: 140-145.
9. Raasch H, Jensen BC, Chang PP, Mounsey JP, Gehi AK, Chung EH, Sheridan B, et al., Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J 2012; 164: 373-378.
10. Garan AR, Yuzefpolskaya M, Colombo PC, Morrow JP, Te-Frey R, Dano D, Takayama H, et al., Ventricular arrhythmias and implantable cardioverter defibrillator therapy in patients with continuous flow left ventricular assist devices. J Am Coll Cardiol 61: 2542-2550.
11. Enriquez AD, Calenda B, Miller M, Anyanwu AC, Pinney SP,. The role of implantable cardioverter defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophtrophysiol 2013; 6: 668-674.
12. Patel P, Williams JG, Brice JH,. Sustained ventricular fibrillation in an alert patient: Preserved hemodynamics with a left ventricular assist device. Prehosp Emerg Care 2011; 15: 533-536.
13. Dewland TA, Chorba JS, Goldschlager N, Marcus GM,. Sustained ventricular fibrillation in a conscious patient. Arch Intern Med 2011; 171: 973.
14. Phan JA, Muthiah K, Robson D, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, et al., Death on an LVAD-two sides of a coin. Heart Lung Circ 2013; 22: 952-954.
15. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S,. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 2007; 99: 1151-1153.
16. Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NG, Starling RC, Wilkoff BL,. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter defibrillator. Heart Rhythm 2010; 7: 466-471.
17. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, et al., Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251.
18. Brenyo A, Rao M, Koneru S, Hallinon W, Shah S, Massey HT, Chen L, et al., Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol 2012; 23: 515-520.
19. Cantillon DJ, Saliba WI, Wazni OM, Kanj M, Starling RC, Tang W, Wilkof BL,. Low cardiac outpit associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT study). J Heart Lung Transplant 2014; 33: 318-320.
20. Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H,. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol 2005; 45: 1428-1434.
21. Volkron M, Voitl P, Ta J, Wieselthaler G, Schima H,. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant 2007; 26: 819-825.
22. Cantillon DJ, Bianco C, Wazni O, Kanj M, Smedira NG, Wilkoff BL, Starling RC, et al., Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support. Heart Rhythm 2012; 9: 859-864.
23. Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC, Brieke A, et al., Implantable cardioverter defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant 2010; 29: 771-776.
24. Foo D, Walker BD, Kuchar DL, Thorburn CW, Tay A, Hayward C, Macdonald P, et al., Left ventricular mechanical assist devices and cardiac device interactions: An observational case series. Pacing Clin Electrophysiol 2009; 32: 879-887.
25. Hohnloser SH, Dorian P, Roberts R, Gent M, Israel CW, Fain E, Champagne J, et al., Effect of amiodarone and sotalol on ventricular defibrillation threshold. The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial. Circulation 2006; 114: 104-109.